The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...

Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.

Users of the FreeStyle Libre 2 and 3 continuous glucose monitoring systems from Abbott no longer need to remove and discard the devices for imaging procedures, such as X-rays, CT ...

Abbott has announced that Tandem Diabetes Care’s t:slim X2 insulin pump has become the first automated insulin delivery (AID) system to integrate with its newly available FreeStyle Libre 2 Plus sensor ...

We are excited to work with Abbott to empower healthcare providers and people ... Tidepool+ will be able to initiate the ...

announced that Abbott has initiated a voluntary recall for a specific batch of FreeStyle Libre® 3 sensors distributed in the ...

Meanwhile, Abbott's FreeStyle Libre and FreeStyle Libre 2 flash CGM systems remain available to patients and listed on the NHS Drug Tariff. The FreeStyle Libre 3 system consists of the sensor ...

Tidepool collaborates with Abbott for seamless data integration ... to initiate the connection with their patients using FreeStyle Libre 2 and 3 systems in clinic or remotely.

A major development towards the goal of patient and provider choice, the cloud-to-cloud integration will provide an automatic stream of data from patients using Abbott’s FreeStyle Libre ...

Abbott's world-leading1 FreeStyle Libre 2 and 3 systems for people living with diabetes are now the only continuous ... Abbott's Volt™ PFA System Global FOCALFLEX trial now underway for Abbott's ...